Bank of Montreal’s IGC Pharma IGC Stock Holding History

Bank of Montreal’s Portfolio IGC Stock Details IGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-45,000	Closed	-$26K	–	4841
2020 Q2	$26K	Hold	45,000	–	–	﹤0.01%	3732
2020 Q1	$20K	Hold	45,000	–	–	﹤0.01%	3246
2019 Q4	$28K	Hold	45,000	–	–	﹤0.01%	4119
2019 Q3	$44K	Hold	45,000	–	–	﹤0.01%	3685
2019 Q2	$74K	Sell	45,000 -20,000	-31%	-$28.3K	﹤0.01%	3501
2019 Q1	$135K	Buy	+65,000	New	+$148K	﹤0.01%	2931

Other funds holding IGC

CFA

Carroll Financial Associates Charlotte, North Carolina $1.88B AUM 20.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dearborn Partners Chicago, Illinois $1.85B AUM 6.59% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Bank of Montreal's IGC Position: Q3 2020 in Review

Bank of Montreal sold out of IGC Pharma (IGC) in Q3 2020, closing a stake of 45,000 shares — an estimated $26K sold.

Bank of Montreal first reported a position in IGC in Q1 2019 and held it in 6 quarters. The position peaked at $135K in Q1 2019. 24 funds tracked by Wall St. Rank hold IGC as of Q3 2020.

Bank of Montreal reported no remaining IGC Pharma position as of Q3 2020 after selling out during the quarter.
Bank of Montreal sold 45,000 IGC Pharma shares in Q3 2020, an estimated $26K.
Bank of Montreal first reported a position in IGC Pharma in Q1 2019 and held it in 6 quarters.
Bank of Montreal's IGC Pharma position peaked at $135K in Q1 2019.
24 funds tracked by Wall St. Rank held IGC Pharma as of Q3 2020.

Based on Bank of Montreal's 13F filing for Q3 2020, filed 12 Nov 2020.